Biomarker Commons

Biomarker Commons is my knowledge curation project, where I continually find, organize and share the best and most relevant content on biomarkers. BiomarkerCommons.org provides consistent, high-quality news and research focused on biomarker discovery, development and use.
Recent articles by Walter Jessen on biomarkers
The Covance Symposium Recent Advances in Biomarkers of Parkinson’s Disease presented at the 2011 Society for Neuroscience Conference is now available to watch on the Covance website. Listen to discussions regarding recent innovations in imaging, genomic, proteomic, and fluid biomarkers of Parkinso [...]
A spinout of Drexel University called QLIDA Diagnostics is developing a mobile cardiac biomarker testing device for use in emergency rooms to rapidly determine whether someone is having a heart attack. The mobile diagnostic test uses a small blood sample to measure the cardiac biomarker troponin. Un [...]
The technology company NVIDIA, best known for its graphics processing units (GPUs), recently announced that BGI is launching a service that will enable researchers worldwide to perform affordable next-generation sequencing (NGS) bioinformatics analysis in the cloud. The new "EasyGenomics" service co [...]
NextBio announced today NextBio Clinical, an extension of the company’s existing life sciences platform to translational medicine applications such as biomarker discovery and clinical trial optimization. NextBio Clinical enables the application of clinical information earlier in the discovery proc [...]
A roundup of five research studies on cancer biomarkers that were presented early last week at the American Association for Cancer Research (AACR) 103nd Annual Meeting in Chicago, Illinois. Baseline Hormone Levels Appear to Predict Survival in Metastatic, Castration-resistant Prostate Cancer Resear [...]
Cleveland HeartLab Inc. (CHL) announced today the launch of a campaign to educate patients and health care professionals about the importance of “it,” or inflammation testing, in determining heart attack and stroke risk. CHL is a specialty clinical laboratory and cardiovascular disease managemen [...]
